top of page

Aries Biotech is Expanding!

Aries Biotech is pleased to announce new hours of operation!

Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommodate increased interest across neuroscience and neurotrauma R&D, product development, novel concepts, and data dissemination.

Visit our Website to make an appointment

Aries Biotech specializes in providing neurological disease and dementia biomarker consulting services. We are dedicated to meeting your specific needs and requirements. Discover how we can enhance your projects by visiting Aries Biotech at:

16 views0 comments

Recent Posts

See All

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

bottom of page